ID
13423
Beskrivning
Antibiotic-associated diarrhoea (AAD) is a frequent condition in hospitalised patients receiving antibiotic treatment. The same is true for Clostridium difficile-associated diarrhoea (CDAD) with even more grave consequences of increased morbidity and mortality. The development and evaluation of preventive strategies is one key public health challenge. In the absence of clinically evaluated alternatives, probiotics have been suggested to be beneficial for the prevention of AAD and CDAD. However, data have so far been inconclusive and recently published meta-analyses strongly recommended large state-of-the-art clinical trials on probiotic substances for the prevention of AAD and CDAD. Since the efficacy, side-effects and modes of action of different probiotic bacteria and yeast are strain specific, benefits and risks cannot be generalised. The non-pathogenic yeast Saccharomyces cerevisiae var. boulardii (Sac. boulardii) is considered the most promising probiotic substance for the prevention of AAD and CDAD. We carry out a randomised, placebo controlled, double blind multicentre clinical trial to evaluate Sac. boulardii for the indication of prevention of AAD and CDAD in 1520 adult, hospitalised patients.
Nyckelord
Versioner (3)
- 2016-02-04 2016-02-04 -
- 2016-02-11 2016-02-11 -
- 2016-02-11 2016-02-11 -
Uppladdad den
11 februari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
SacBo TI: Case Report Form Phone Interview Medication Obligatory For Documentation DRKS00000084 NCT01143272
SacBo TI: Case Report Form Phone Interview Medication Obligatory For Documentation NCT01143272
Beskrivning
Treatment with drugs/opiates causing constipation
Beskrivning
line
Datatyp
integer
Beskrivning
medication name
Datatyp
text
Alias
- UMLS CUI [1]
- C2360065
Beskrivning
first dose
Datatyp
date
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205435
- UMLS CUI [1,3]
- C0011008
Beskrivning
Date of first dose unknown
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205435
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [1,4]
- C0011008
Beskrivning
Date of last dose
Datatyp
date
Alias
- UMLS CUI [1]
- C1762893
Beskrivning
Date of last dose unknown
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1762893
- UMLS CUI [1,2]
- C0439673
Beskrivning
Treatment with systemic antifungal agents; note that the use of systemic antifungal agents makes the patient retrospectively ineligible for this study as of exclusion criterion 06; please record early study termination if this is the case
Beskrivning
Line
Datatyp
integer
Beskrivning
medication name
Datatyp
text
Alias
- UMLS CUI [1]
- C2360065
Beskrivning
first dose
Datatyp
date
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205435
- UMLS CUI [1,3]
- C0011008
Beskrivning
Date of first dose unknown
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0205435
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [1,4]
- C0011008
Beskrivning
Date of last dose
Datatyp
date
Alias
- UMLS CUI [1]
- C1762893
Beskrivning
Date of last dose unknown
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1762893
- UMLS CUI [1,2]
- C0439673
Similar models
SacBo TI: Case Report Form Phone Interview Medication Obligatory For Documentation NCT01143272
C1515021 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0003232 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0439673 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
C0439673 (UMLS CUI [1,2])
Inga kommentarer